Amgen, Selexis Expand Deal to Include Evaluation of Mammalian Cell Line
February 20, 2013
Amgen, Selexis Expand Deal to Include Evaluation of Mammalian Cell Line
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Ventana Sublicensing IP from Gen-Probe for ERG Protein Measurement
May 21, 2012 / GenomeWeb Daily News - Empire Genomics Licenses Biomarker from Cornell to Develop Prostate Cancer Dx
May 22, 2013 / GenomeWeb Daily News - Qiagen to Distribute Sygnis Pharma Amplification Buffer Under Licensing Pact
May 16, 2013 / PCR Insider - Sygnis Licenses Amplification Buffer to Qiagen
May 16, 2013 / GenomeWeb Daily News - Transgenomic to Develop RAS Mutation Test with Amgen for Metastatic CRC Patients
May 15, 2013 / Pharmacogenomics Reporter